ATYR
Price
$3.42
Change
-$0.10 (-2.84%)
Updated
Apr 24, 02:17 PM (EDT)
Capitalization
311.01M
13 days until earnings call
MGTX
Price
$6.55
Change
+$0.06 (+0.92%)
Updated
Apr 24, 02:41 PM (EDT)
Capitalization
494.42M
14 days until earnings call
Ad is loading...

ATYR vs MGTX

Header iconATYR vs MGTX Comparison
Open Charts ATYR vs MGTXBanner chart's image
aTyr Pharma
Price$3.42
Change-$0.10 (-2.84%)
Volume$629
Capitalization311.01M
MeiraGTx Holdings
Price$6.55
Change+$0.06 (+0.92%)
Volume$100
Capitalization494.42M
ATYR vs MGTX Comparison Chart
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. MGTX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a StrongBuy and MGTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ATYR: $3.50 vs. MGTX: $6.49)
Brand notoriety: ATYR and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 83% vs. MGTX: 68%
Market capitalization -- ATYR: $311.01M vs. MGTX: $494.42M
ATYR [@Biotechnology] is valued at $311.01M. MGTX’s [@Biotechnology] market capitalization is $494.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ATYR is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 5 TA indicator(s) are bullish while MGTX’s TA Score has 4 bullish TA indicator(s).

  • ATYR’s TA Score: 5 bullish, 5 bearish.
  • MGTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATYR is a better buy in the short-term than MGTX.

Price Growth

ATYR (@Biotechnology) experienced а +15.89% price change this week, while MGTX (@Biotechnology) price change was +21.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

ATYR is expected to report earnings on Aug 13, 2025.

MGTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($494M) has a higher market cap than ATYR($311M). MGTX YTD gains are higher at: 6.568 vs. ATYR (-3.315). ATYR has higher annual earnings (EBITDA): -66.37M vs. MGTX (-121.84M). MGTX has more cash in the bank: 104M vs. ATYR (72.1M). ATYR has less debt than MGTX: ATYR (13.3M) vs MGTX (84.8M). MGTX has higher revenues than ATYR: MGTX (33.3M) vs ATYR (235K).
ATYRMGTXATYR / MGTX
Capitalization311M494M63%
EBITDA-66.37M-121.84M54%
Gain YTD-3.3156.568-50%
P/E RatioN/AN/A-
Revenue235K33.3M1%
Total Cash72.1M104M69%
Total Debt13.3M84.8M16%
FUNDAMENTALS RATINGS
ATYR vs MGTX: Fundamental Ratings
ATYR
MGTX
OUTLOOK RATING
1..100
1720
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
4155
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MGTX's Valuation (63) in the Biotechnology industry is in the same range as ATYR (84) in the null industry. This means that MGTX’s stock grew similarly to ATYR’s over the last 12 months.

ATYR's Profit vs Risk Rating (95) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that ATYR’s stock grew similarly to MGTX’s over the last 12 months.

ATYR's SMR Rating (95) in the null industry is in the same range as MGTX (96) in the Biotechnology industry. This means that ATYR’s stock grew similarly to MGTX’s over the last 12 months.

ATYR's Price Growth Rating (41) in the null industry is in the same range as MGTX (55) in the Biotechnology industry. This means that ATYR’s stock grew similarly to MGTX’s over the last 12 months.

ATYR's P/E Growth Rating (100) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that ATYR’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATYRMGTX
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
83%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKMCX38.06N/A
N/A
Fidelity Mid-Cap Stock K
TIMVX16.10N/A
N/A
Nuveen Mid Cap Value R6
EQNVX19.96N/A
N/A
MFS Equity Income R6
TGPEX9.85N/A
N/A
T. Rowe Price Global Impact Equity Inv
ASCYX8.62N/A
N/A
Alger Small Cap Growth Y

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
+0.86%
MGTX - ATYR
45%
Loosely correlated
+3.51%
NTLA - ATYR
39%
Loosely correlated
-2.65%
CRNX - ATYR
37%
Loosely correlated
+3.55%
AMLX - ATYR
36%
Loosely correlated
+2.85%
SLDB - ATYR
36%
Loosely correlated
+3.50%
More